申请人:MERZ PHARMA GMBH & CO KGAA
公开号:WO2012164085A1
公开(公告)日:2012-12-06
The invention relates to 2(1H)-quinolinone derivatives of formula (I) as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.
该发明涉及公式(I)的2(1H)-喹啉酮衍生物及其药用可接受的盐。该发明还涉及一种制备此类化合物的方法。该发明的化合物是甘氨酸B拮抗剂,因此对于控制和预防各种疾病,包括神经系统疾病,具有用途。